港股異動 | 中國利郎(1234.HK)跌逾4% 去年淨利同比下降31.4%
格隆匯3月19日丨中國利郎(1234.HK)股價直線下跌,最低見5.02港元,最大跌幅近6%,現回升至5.12港元,跌幅縮至4.3%,最新總市值61.3億港元。公司昨日公吿稱,截至2020年12月31日止年度,集團實現收入26.81億元人民幣(單位下同),同比下降26.7%;毛利12.04億元,同比下降14.2%;年內淨利潤5.57億元,同比下降31.4%;宣派末期股息每股19港仙及特別末期股息每股8港仙。利潤下降主要是由於年內銷售收入減少、以及預提產品回購撥備所致。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.